Van Overveld FJ - Search Results

1

Synergism between interleukin-1 beta and interferon-gamma, an inducer of nitric oxide synthase, in rat lung fibroblasts.

Jorens PG, Van Overveld FJ, Vermeire PA, Bult H, Herman AG. Jorens PG, et al. Among authors: van overveld fj. Eur J Pharmacol. 1992 Nov 24;224(1):7-12. doi: 10.1016/0014-2999(92)94811-9. Eur J Pharmacol. 1992. PMID: 1280597

2

Pterins inhibit nitric oxide synthase activity in rat alveolar macrophages.

Jorens PG, van Overveld FJ, Bult H, Vermeire PA, Herman AG. Jorens PG, et al. Among authors: van overveld fj. Br J Pharmacol. 1992 Dec;107(4):1088-91. doi: 10.1111/j.1476-5381.1992.tb13411.x. Br J Pharmacol. 1992. PMID: 1281717 Free PMC article.

3

Soybean trypsin inhibitor and beta-amylase induce alveolar macrophages to release nitrogen oxides.

Jorens PG, Van Overveld FJ, Bult H, Vermeire PA, Herman AG. Jorens PG, et al. Among authors: van overveld fj. Biochem Pharmacol. 1992 Jul 22;44(2):387-90. doi: 10.1016/0006-2952(92)90025-e. Biochem Pharmacol. 1992. PMID: 1386512

4

L-arginine-dependent production of nitrogen oxides by rat pulmonary macrophages.

Jorens PG, Van Overveld FJ, Bult H, Vermeire PA, Herman AG. Jorens PG, et al. Among authors: van overveld fj. Eur J Pharmacol. 1991 Aug 6;200(2-3):205-9. doi: 10.1016/0014-2999(91)90573-9. Eur J Pharmacol. 1991. PMID: 1782986

5

Muramyldipeptide and granulocyte-macrophage colony-stimulating factor enhance interferon-gamma-induced nitric oxide production by rat alveolar macrophages.

Jorens PG, van Overveld FJ, Bult H, Vermeire PA, Herman AG. Jorens PG, et al. Among authors: van overveld fj. Agents Actions. 1993 Jan;38(1-2):100-5. doi: 10.1007/BF02027220. Agents Actions. 1993. PMID: 8480530

6

Interleukin-8 production in patients undergoing cardiopulmonary bypass. The influence of pretreatment with methylprednisolone.

Jorens PG, De Jongh R, De Backer W, Van Damme J, Van Overveld F, Bossaert L, Walter P, Herman AG, Rampart M. Jorens PG, et al. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):890-5. doi: 10.1164/ajrccm/148.4_Pt_1.890. Am Rev Respir Dis. 1993. PMID: 8214944 Clinical Trial.

7

Release of arachidonic acid metabolites from isolated human alveolar type II cells.

van Overveld FJ, Jorens PG, De Backer WA, Rampart M, Bossaert L, Vermeire PA. van Overveld FJ, et al. Prostaglandins. 1992 Aug;44(2):101-10. doi: 10.1016/0090-6980(92)90071-z. Prostaglandins. 1992. PMID: 1438874

8

Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase.

van Overveld FJ, Jorens PG, Rampart M, de Backer W, Vermeire PA. van Overveld FJ, et al. Clin Exp Allergy. 1991 Nov;21(6):711-4. doi: 10.1111/j.1365-2222.1991.tb03200.x. Clin Exp Allergy. 1991. PMID: 1723344

9

Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury.

Jorens PG, Sibille Y, Goulding NJ, van Overveld FJ, Herman AG, Bossaert L, De Backer WA, Lauwerys R, Flower RJ, Bernard A. Jorens PG, et al. Among authors: van overveld fj. Eur Respir J. 1995 Oct;8(10):1647-53. doi: 10.1183/09031936.95.08101647. Eur Respir J. 1995. PMID: 8586116 Free article.

10

Induced sputum of patients with chronic obstructive pulmonary disease (COPD) contains adhesion-promoting, therapy-sensitive factors.

van Overveld FJ, Vermeire PA, De Backer WA. van Overveld FJ, et al. Inflamm Res. 2000 Jan;49(1):8-13. doi: 10.1007/PL00000203. Inflamm Res. 2000. PMID: 10778915 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters